China Oncology

Loading...

Welcome to China Oncology,

China Oncology

30 January 2021, Volume 31 Issue 1 Previous Issue Next Issue

Cover and contents

2021 Issue 1 Cover

Abstract ( 273) PDF (2572KB) ( 880 )

Contents of Issue 1, 2021

2021, 31 (1): 82-.

Abstract ( 194) PDF (243KB) ( 757 )

Specialists’ Commentary and Article

Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2020

TANG Rong, SHI Si, ZHANG Bo, XU Jin, WANG Wei, YU Xianjun

2021, 31 (1): 1-10. doi: 10.19401/j.cnki.1007-3639.2021.01.001

Abstract ( 989) PDF (1149KB) ( 3031 )

Metastasis patterns and survival analysis of 20 000 patients with metastasis from a hospital-based cancer registry database

FENG Xiaoshuang , ZHOU Changming , MO Miao , YUAN Jing , SHEN Jie , WANG Zezhou , ZHANG Zhihong , QIN Yiyu , WU Jiong , ZHENG Ying , GUO Xiaomao

2021, 31 (1): 11-19. doi: 10.19401/j.cnki.1007-3639.2021.01.002

Abstract ( 966) PDF (2300KB) ( 1610 )

Article

Effects of SLC6A3 downregulation on proliferation and migration of SNU-349 cells in renal clear cell carcinoma

WANG Jia , AI Zhongzhong , ZHOU Jing

2021, 31 (1): 20-26. doi: 10.19401/j.cnki.1007-3639.2021.01.003

Abstract ( 637) PDF (2619KB) ( 1339 )

miR-375 targeting YAP1 modulates trastuzumab resistance through epithelial-mesenchymal transition in breast cancer cells

YE Xingming , WANG Lin , JIA Jing , WU Xiufeng , CHEN Ying

2021, 31 (1): 27-34. doi: 10.19401/j.cnki.1007-3639.2021.01.004

Abstract ( 610) PDF (3784KB) ( 1620 )

miR-122-5p inhibits the growth of esophageal cancer cells and transplanted tumors by targeting CREB1

CHEN Shaogeng, HE Rongqi, ZHANG Wanfei, LIN Xianzuan, CHEN Heshan, XU Rongyu

2021, 31 (1): 35-44. doi: 10.19401/j.cnki.1007-3639.2021.01.005

Abstract ( 503) PDF (3615KB) ( 1576 )

Impact of metastatic organ on prognosis in extensive-stage small cell lung cancer

LIU Qian , QIAO Meng , MAO Shiqi , YANG Shuo , LIU Yiwei , ZHAO Chao , LI Xuefei , REN Shengxiang , ZHOU Caicun

2021, 31 (1): 45-51. doi: 10.19401/j.cnki.1007-3639.2021.01.006

Abstract ( 904) PDF (2023KB) ( 1876 )

Risk factors analysis of liver injury induced by chemotherapy in patients with breast cancer

LIU Jiawei, LI Dan, ZHAI Qing

2021, 31 (1): 52-62. doi: 10.19401/j.cnki.1007-3639.2021.01.007

Abstract ( 734) PDF (1148KB) ( 2045 )

A study of neutrophil to lymphocyte ratio for the prediction of axillary pathological complete response after neoadjuvant therapy in breast cancer

BI Zhao , SONG Xianrang , CHEN Peng , XIE Li , JIANG Wei , SONG Xingguo , CONG Binbin , WANG Yongsheng

2021, 31 (1): 63-68. doi: 10.19401/j.cnki.1007-3639.2021.01.008

Abstract ( 636) PDF (947KB) ( 1895 )

Review

Clinical research progress of tumor mutational burden in EGFR-mutant advanced non-small cell lung cancer

HE Xi, JIAO Xiaodong, ZANG Yuansheng

2021, 31 (1): 69-75. doi: 10.19401/j.cnki.1007-3639.2021.01.009

Abstract ( 710) PDF (1081KB) ( 2221 )

Research advances in abnormal lipid metabolism of lung cancer

ZHANG Cuicui, QIN Tingting, MENG Zhaoting, LI Kai

2021, 31 (1): 76-80. doi: 10.19401/j.cnki.1007-3639.2021.01.010

Abstract ( 673) PDF (987KB) ( 2417 )

中国癌症杂志

Database Indexing

A Guide to the Core Journals of China
Chinese Science Citation Database (CSCD)
China National Knowledge Infrastructure (CNKI)
Chinese Sci-tech Paper and Citation Database (CSTPCD)
Outsanding S&T Journals of China (2020) (F5000)
World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (2021)
SCOPUS
EMBASE
DOAJ
Chemical Abstracts (CA)
Japan Science and Technology Database (JST)
The Western Pacific Region Index Medicus (WPRIM)
EBSCO
Index of Copernicus International (ICI)

Competent Authorities

　The Ministry of Education of the People’s Republic of China

Sponsored by

　Fudan University Shanghai Cancer Center

Edited by

　Editorial Board of China Oncology

Editor-in-Chief

　SHAO Zhimin

Honorary Editor-in-Chief

　TANG Zhaoyou, CAO Shilong, SHEN Zhenzhou

Printed by

　Shanghai Ouyang Printing Co., Ltd.

WeChat